Sugi Predict

Sugi Predict / Compounds / SCHEMBL30880899

SCHEMBL30880899

SCHEMBL30880899

CC(C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CC(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@@H](C)O

nearest known ligand 0.63

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ GLP1R P43220 20/20 0.63
▸ GCGR P47871 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29430203 0.93 GLP1R (0.61) GLP1RGCGR
SCHEMBL29479876 0.91 GLP1R (0.70) GLP1R
SCHEMBL30433096 0.91 GLP1R (0.71) GLP1RGCGR
SCHEMBL31683286 0.91 GLP1R (0.63) GLP1R
SCHEMBL30578727 0.90 IL23R (0.62) —
SCHEMBL30880886 0.89 IL23R (0.61) GLP1R
SCHEMBL30567781 0.89 GLP1R (0.66) GLP1RGCGR
SCHEMBL30440774 0.88 GLP1R (0.57) GLP1R
SCHEMBL30495781 0.86 GLP1R (0.61) GLP1R
SCHEMBL30512611 0.86 KISS1R (0.57) GLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570729-B2 Antibody fragment based antifungal conjugate selectively targeting candida ABGENICS LIFESCIENCES PRIVATE LIMITED (IN) 2026-03-10 — — US disclosed
US-20240092878-A1 AN ANTIBODY FRAGMENT BASED ANTIFUNGAL CONJUGATE SELECTIVELY TARGETING CANDIDA ABGENICS LIFESCIENCES PRIVATE LIMITED (IN) 2024-03-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570729-B2 Antibody fragment based antifungal conjugate selectively targeting candida SERPINH1, HM13, NGLY1 GLP1R 2596/4885GCGR 3575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback